DexCom Inc at Robert W Baird Global Healthcare Conference Transcript
All right, guys. I think we are live. I'm just trying to get my screens set over to my laptop, and there I go. I'm good. So good afternoon, everyone. Sorry, a little technical difficulty there. But I think we'll get started. My name is Jeff Johnson. I'm the Senior Medical Technology Analyst at Baird. Our next presentation this afternoon is from DexCom, a continuous glucose monitor manufacturer that currently enjoys a leading share of the nearly $4 billion global CGM market. With us today from DexCom, we're pleased to have Executive Vice President of Strategy and Corporate Development, Steve Pacelli; and Senior Vice President of Finance and Chief Accounting Officer, Jereme Sylvain. So guys, I think we're just going to go straight into Q&A, and we're running a couple of minutes behind, so why don't we just do that. So thank you for joining us. It's good to see you.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |